HIGHLIGHTS
- who: Breast cancer et al. from the (UNIVERSITY) have published the research: sTIL - A Predictor of pCR in Process: Submission:03/18/2022 Acceptance:08/07/2022 Stromal Tumor Infiltrating Lymphocytes (sTIL) as an Independent Predictor of Pathologic Response to Neadjuvant Chemotherapy in in_Indonesia: A Hospital-based Study, in the Journal: (JOURNAL)
- what: The authors aim to describe the sTIL profiles of Indonesian patient and its role in predicting neoadjuvant chemotherapy response.
SUMMARY
Partial tumor reduction was reported in 40.48% of patients, minimal tumor reduction in 19.05% patients, and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.